Table of contents
Volume 89, Issue 5
Published online 26 August 2003 (779-955)
Tutorial Paper |
Clinical |
Epidemiology |
Molecular and Cellular Pathology |
Experimental Therapeutics |
Letters to the Editor
Editorial
Osteoporosis and prostate cancer FREE
T Dhillon and J Waxman
Br J Cancer 89: 779-780; doi:10.1038/sj.bjc.6601191
Tutorial Paper
Survival Analysis Part IV: Further concepts and methods in survival analysis FREE
T G Clark, M J Bradburn, S B Love and D G Altman
Br J Cancer 89: 781-786; doi:10.1038/sj.bjc.6601117
Clinical
Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer FREE
C Kloft, W Siegert and U Jaehde
Br J Cancer 89: 787-794; doi:10.1038/sj.bjc.6601215
Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer FREE
K Kiura, H Ueoka, Y Segawa, M Tabata, H Kamei, N Takigawa, S Hiraki, Y Watanabe, A Bessho, K Eguchi, N Okimoto, S Harita, M Takemoto, Y Hiraki, M Harada and M Tanimoto for the Okayama Lung Cancer Study Group
Br J Cancer 89: 795-802; doi:10.1038/sj.bjc.6601217
Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer FREE
H Yoshizawa, J Tanaka, H Kagamu, Y Maruyama, H Miyao, K Ito, T Sato, A Iwashima, E Suzuki and F Gejyo
Br J Cancer 89: 803-807; doi:10.1038/sj.bjc.6601227
A phase 1 study of tazarotene in adults with advanced cancer FREE
P H Jones, R D Burnett, I Fainaru, P Nadolny, P Walker, Z Yu, D Tang-Liu, T S Ganesan, D C Talbot, A L Harris and G J S Rustin
Br J Cancer 89: 808-815; doi:10.1038/sj.bjc.6601169
Plasma concentrations of 5-fluorouracil and F-
-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil FREE
Y Yamada, T Hamaguchi, M Goto, K Muro, Y Matsumura, Y Shimada, K Shirao and S Nagayama
Br J Cancer 89: 816-820; doi:10.1038/sj.bjc.6601224
Providing cancer services to remote and rural areas: consensus study FREE
L Stevenson, N C Campbell and P A Kiehlmann
Br J Cancer 89: 821-827; doi:10.1038/sj.bjc.6601166
Epidemiology
Socioeconomic variation in colon cancer tumour factors associated with poorer prognosis FREE
G Lyratzopoulos, C R West and E M I Williams
Br J Cancer 89: 828-830; doi:10.1038/sj.bjc.6601192
Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies FREE
K Matsumoto, T Yasugi, A Oki, H Hoshiai, Y Taketani, T Kawana and H Yoshikawa
Br J Cancer 89: 831-833; doi:10.1038/sj.bjc.6601220
Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area FREE
S Bulk, O Visser, L Rozendaal, R H M Verheijen and C J L M Meijer
Br J Cancer 89: 834-839; doi:10.1038/sj.bjc.6601157
Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment FREE
C Rubino, F de Vathaire, A Shamsaldin, M Labbe and M G Lê
Br J Cancer 89: 840-846; doi:10.1038/sj.bjc.6601138
Physical activity and risk of breast cancer in premenopausal women FREE
G A Colditz, D Feskanich, W Y Chen, D J Hunter and W C Willett
Br J Cancer 89: 847-851; doi:10.1038/sj.bjc.6601175
Life-course body size and perimenopausal mammographic parenchymal patterns in the MRC 1946 British birth cohort FREE
V A McCormack, I dos Santos Silva, B L De Stavola, N Perry, S Vinnicombe, A J Swerdlow, R Hardy and D Kuh
Br J Cancer 89: 852-859; doi:10.1038/sj.bjc.6601207
Molecular and Cellular Pathology
Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma FREE
M L Yager, J A I Hughes, F J Lovicu, P W Gunning, R P Weinberger and G M O'Neill
Br J Cancer 89: 860-863; doi:10.1038/sj.bjc.6601201
Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation FREE
J N E Ashman, H S Patmore, L T Condon, L Cawkwell, N D Stafford and J Greenman
Br J Cancer 89: 864-869; doi:10.1038/sj.bjc.6601199
Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? FREE
R Cooper, S Sario
lu, S Sökmen, M Füzün, A Küpeliolu, H Valentine, I B Görken, R Airley and C West
Br J Cancer 89: 870-876; doi:10.1038/sj.bjc.6601202
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis FREE
M I Koukourakis, A Giatromanolaki, E Sivridis, G Bougioukas, V Didilis, K C Gatter and A L Harris for the 'Tumour and Angiogenesis Research Group'
Br J Cancer 89: 877-885; doi:10.1038/sj.bjc.6601205
Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections FREE
R L M Bekkers, J Bulten, A Wiersma-van Tilburg, M Mravunac, C P T Schijf, L F A G Massuger, W G V Quint and W J G Melchers
Br J Cancer 89: 886-890; doi:10.1038/sj.bjc.6601204
Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer FREE
C M Holland, K Day, A Evans and S K Smith
Br J Cancer 89: 891-898; doi:10.1038/sj.bjc.6601194
Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers FREE
D Vernimmen, M Gueders, S Pisvin, P Delvenne and R Winkler
Br J Cancer 89: 899-906; doi:10.1038/sj.bjc.6601200
Experimental Therapeutics
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth FREE
I-S Park, S-W Kang, Y-J Shin, K-Y Chae, M-O Park, M-Y Kim, D N Wheatley and B-H Min
Br J Cancer 89: 907-914; doi:10.1038/sj.bjc.6601181
Malignant germ cell tumours of the testis express interferon-
, but are resistant to endogenous interferon-
FREE
S Schweyer, A Soruri, J Peters, A Wagner, H J Radzun and A Fayyazi
Br J Cancer 89: 915-921; doi:10.1038/sj.bjc.6601209
Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide FREE
T Kanzawa, I M Germano, Y Kondo, H Ito, S Kyo and S Kondo
Br J Cancer 89: 922-929; doi:10.1038/sj.bjc.6601193
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue FREE
B Chini, M Chinol, P Cassoni, S Papi, A Reversi, L Areces, T Marrocco, G Paganelli, M Manning and G Bussolati
Br J Cancer 89: 930-936; doi:10.1038/sj.bjc.6601189
Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy FREE
M R Hamblin, J L Miller, I Rizvi, H G Loew and T Hasan
Br J Cancer 89: 937-943; doi:10.1038/sj.bjc.6601210
Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil FREE
D H Palmer, A E Milner, D J Kerr and L S Young
Br J Cancer 89: 944-950; doi:10.1038/sj.bjc.6601211
Letters to the Editor
Glucocorticoid use and skin cancers FREE
M P Purdue
Br J Cancer 89: 951-952; doi:10.1038/sj.bjc.6601221
Reply: Glucocorticoid use and skin cancers FREE
M R Karagas and D W Nierenberg
Br J Cancer 89: 952-953; doi:10.1038/sj.bjc.6601222
Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition FREE
C B Seymour, C Mothersill and M Moriarty
Br J Cancer 89: 954; doi:10.1038/sj.bjc.6601188
Breast cancer and tobacco smoke FREE
A J Wells
Br J Cancer 89: 955; doi:10.1038/sj.bjc.6601182
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
